Medical News

RSS

Rising Medicare premiums and no cost-of-living adjustment can reduce Social Security payments

The combination of rising Medicare premiums and no annual cost-of-living adjustment (COLA) would reduce Social Security payments for about 23 million of the nation's seniors in 2011, according to The Senior Citizens League. This figure represents two-thirds of the 37 million seniors who receive Social Security benefits.

21 Sep 2010

Bioconnect's Optiflow Vascular Anastomotic System granted CE mark approval

Bioconnect Systems, Inc. today announced CE mark approval for the Optiflow™ Vascular Anastomotic System. The Optiflow™ enhances a surgeon's ability to create precise vascular connections. The initial indication is the creation of an arteriovenous fistula needed for vascular access in hemodialysis patients.

21 Sep 2010

Access enters $30M supply agreement for MuGard with RHEI

Access Pharmaceuticals, Inc., a biopharmaceutical company specializing in products for cancer and supportive care signed a $30 million supply agreement for MuGard with RHEI Pharmaceuticals, Inc., a specialty pharmaceutical company focused on bringing proprietary medicines to the China market. Access will ensure manufacturing capacity of up to a minimum of $30 million of product in the licensed territories.

21 Sep 2010

Echo commences development of new transdermal biosensor for continuous lactate monitoring

Echo Therapeutics, Inc., a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude™ SkinPrep System for transdermal drug delivery, today announced that it is beginning a development program designed to create a new transdermal biosensor for continuous lactate monitoring to be used in critical care and sports medicine.

21 Sep 2010

Biodegradable polymers represent future of stent design

Three-year data demonstrated that satisfactory clinical and safety outcomes of sirolimus eluting stents with a biodegradable polymer were sustained in a real world setting. The results were presented at the 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation.

21 Sep 2010

Greenway announces advanced allergy module in integrated EHR solution

Greenway Medical Technologies, Inc. today announced the most advanced allergy module available in an integrated electronic health record (EHR) solution for ear, nose and throat (ENT) and allergy physician practices. Developed in conjunction with a leading ENT and allergy testing and treatment practice, the Greenway® Allergy Module for PrimeSuite® provides unmatched allergy testing, serum creation, allergy shot record, lot maintenance and reporting functionality for today's ENT and allergy practice groups.

21 Sep 2010

Optimer submits fidaxomicin rolling NDA for treatment of Clostridium difficile infection

Optimer Pharmaceuticals, Inc. today announced that it has submitted the first section of a rolling New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for fidaxomicin to treat patients with Clostridium difficile infection (CDI) and to prevent recurrences of CDI. Optimer anticipates completing the submission in the fourth quarter of 2010 and plans to request priority review, which, if granted, could lead to an FDA decision on the NDA in the second quarter of 2011.

21 Sep 2010

PROMUS Element Stent receives expanded indications approval for high-risk diabetic and AMI patient groups

Boston Scientific Corporation today announced that its PROMUS® Element™ Everolimus-Eluting Coronary Stent System has received CE Mark approval for use in patients with diabetes and those experiencing an acute myocardial infarction (AMI), or heart attack.

21 Sep 2010

MD Analytics releases early results from annual Pharmacists Prescribing report

Health industry marketing research leader MD Analytics® released early results today from its annual Insight Syndication Report: Pharmacists Prescribing.

21 Sep 2010

New provincial framework released to improve patient safety for Albertans

A new provincial framework released today will guide, direct and support continuous and measureable improvement of patient safety for Albertans. The purpose of the framework is to develop and advance patient safety strategies in Alberta's health care system with the goal of creating a safer system.

21 Sep 2010

Incidence of hockey-related injuries among children doubles

The incidence of hockey-related injuries among children aged 9 to 14 leading to emergency department visits more than doubled between 1990 and 2006, according to a new nationwide study.

21 Sep 2010

Aethlon Medical reestablishes efforts to advance Aethlon Hemopurifier

Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, disclosed today that it has reestablished efforts to advance the Aethlon Hemopurifier within U.S. Government programs that support the development and purchase of treatment countermeasures against bioterror threats.

21 Sep 2010

Lehigh Valley Health Network automates IRB processes with Click Commerce eResearch Portal software

Click Commerce, the pioneer in customer-configurable solutions for the business of research, announced today that Lehigh Valley Health Network (LVHN) will use the company's eResearch Portal software to automate its Institutional Review Board (IRB) processes, which monitor the safe and ethical conduct of research involving human subjects.

21 Sep 2010

HHS awards ICF International $11.7M contract under CDC task order

ICF International, a leading provider of consulting services and technology solutions to government and commercial clients, has been awarded a new $11.7 million contract by the U.S. Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC). The contract has a term of three years. The contract is awarded under a CDC National Center for Birth Defects and Developmental Disabilities ID/IQ task order.

21 Sep 2010

HealthWarehouse.com, Columbia Medical Associates announce partnership to provide generic prescription medications

HealthWarehouse.com, Inc., a leading retail mail-order online pharmacy and Columbia Medical Associates, an outpatient clinic system offering medical services in the Spokane, Washington metropolitan area, announced a partnership to offer patients a 30-day supply of more than 300 generic prescription medications for $3.50 with free home delivery.

21 Sep 2010

EffRx, Nycomed announce European filing for EX101 marketing approval

EffRx Pharmaceuticals SA and its partner, the global pharmaceutical company Nycomed, headquartered in Zurich, Switzerland, today announced that the first European filing for marketing approval of EX101, a once-a-week 70mg buffered effervescent alendronate, for the treatment of osteoporosis, has been submitted. The filing triggers a milestone payment to EffRx.

21 Sep 2010

Richmond Hill Children's Clinic patients to have real-time access to PHRs at mypatientaccess.ca

Canadian Patient Access Inc. and Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical records (EMR) software and related services today announce that mypatientaccess.ca, Canada's first secure, interactive patient portal will soon be made available to parents of more than 10,000 pediatric patients treated at the Richmond Hill Children's Clinic (Richmond Hill, ON).

21 Sep 2010

Five Prime Therapeutics receives patent for lead oncology product

Five Prime Therapeutics, Inc. today announced it has been issued two patents, U.S. Patent No. 7,678,890 and European Patent No.1910542B1, with claims covering various engineered Fibroblast Growth Factor Receptor ("FGFR") fusion proteins, including composition of matter claims for its lead oncology product, FP-1039.

21 Sep 2010

Semantic Stimuli Response Measurement technology measures response of subconscious mind

The National Mental Health Association reports that over 65 million Americans suffer from some type of mental illness and that 1 in 5 people will experience some mental illness during their life. By 2020, mental illness is projected to be the leading cause of disease burden in North America, an obviously staggering problem with total costs to society running into the hundreds of billions every year.

21 Sep 2010

Phenex Pharmaceuticals announces closure of Series C financing round

Phenex Pharmaceuticals AG, a drug discovery and development company headquartered in Ludwigshafen, Germany, today announced the closure of its Series C financing round with a volume of 6 M € (7,8 M USD) bringing the total amount of funds raised to 17,2 M € (22,4 M USD).

21 Sep 2010

Medical News

Rising Medicare premiums and no cost-of-living adjustment can reduce Social Security payments

Bioconnect's Optiflow Vascular Anastomotic System granted CE mark approval

Access enters $30M supply agreement for MuGard with RHEI

Echo commences development of new transdermal biosensor for continuous lactate monitoring

Biodegradable polymers represent future of stent design

Greenway announces advanced allergy module in integrated EHR solution

Optimer submits fidaxomicin rolling NDA for treatment of Clostridium difficile infection

PROMUS Element Stent receives expanded indications approval for high-risk diabetic and AMI patient groups

MD Analytics releases early results from annual Pharmacists Prescribing report

New provincial framework released to improve patient safety for Albertans

Incidence of hockey-related injuries among children doubles

Aethlon Medical reestablishes efforts to advance Aethlon Hemopurifier

Lehigh Valley Health Network automates IRB processes with Click Commerce eResearch Portal software

HHS awards ICF International $11.7M contract under CDC task order

HealthWarehouse.com, Columbia Medical Associates announce partnership to provide generic prescription medications

EffRx, Nycomed announce European filing for EX101 marketing approval

Richmond Hill Children's Clinic patients to have real-time access to PHRs at mypatientaccess.ca

Five Prime Therapeutics receives patent for lead oncology product

Semantic Stimuli Response Measurement technology measures response of subconscious mind

Phenex Pharmaceuticals announces closure of Series C financing round

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News